MECHANISM STUDY OF RESISTANCE TO THE TARGETED DRUG IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Hui Jin, 294573

GENOME-WIDE CRISPR/CAS9 SCREENING REVEALS NOVEL TARGET GENES, WHOSE INACTIVATION IS ABLE TO UPREGULATE SURFACE EXPRESSION OF IMMUNOTHERAPY TARGET CD20

EHA Library, Helena Peschelova, 294574

UTILIZATION OF NEXT GENERATION SEQUENCING TECHNOLOGY FOR EARLY DETECTION OF CHRONIC LYMPHOCYTIC LEUKEMIA UP TO 21 YEARS BEFORE DIAGNOSIS

EHA Library, Pieter Martijn Kolijn, 294575

T CELL RECEPTOR IMMUNOPROFILING IN SUBGROUPS OF CLL PATIENTS WITH DISTINCT GENOMIC ABERRATIONS

EHA Library, Elisavet Vlachonikola, 294576

INTERLABORATORY COMPARISON OF NGS METHODS FOR DETECTION OF TP53 VARIANTS <10% VAF: THE FIRST PHASE OF AN ERIC MULTICENTER STUDY ON THE CLINICAL IMPACT OF LOW-FREQUENT TP53 VARIANTS IN CLL

EHA Library, Sarka Pavlova, 294577

GSK3Β IS A CRITICAL COMPONENT OF THE SIGNALING NETWORK REGULATING NOTCH1 ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Paolo Sportoletti, 294578

DEVELOPMENT OF A NOVEL PROGNOSTIC MODEL BASED ON M6A RNA METHYLATION REGULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ya Zhang, 294579

MECHANISMS CONFERRING RESISTANCE TO VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA

EHA Library, Daniela Steinbrecher, 294580

TP53 ABERRANT CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH INDOLENT CLINICAL COURSE EXHIBIT A DISTINCT IMMUNE SIGNALING TRANSCRIPTOMIC SIGNATURE

EHA Library, Kostas Stamatopoulos, 294581

IBRUTINIB ENHANCES MACROPHAGE-DEPENDENT THERAPY RESPONSES OF ANTIBODY COMBINATION THERAPY VIA JAK2 INHIBITION OF TARGET B-CELLS

EHA Library, Verena Barbarino, 294582

DISSECTING DIFFERENT ANATOMICAL COMPARTMENTS OF SMALL LYMPHOCYTIC LYMPHOMA WITH A LIQUID BIOPSY APPROACH

EHA Library, Riccardo Moia, 294583

MIR181A IS A NOVEL KEY PLAYER IN THE STAT3-MEDIATED SURVIVAL NETWORK IN TCRΑΒ CD8+ T-LGL LEUKEMIA

EHA Library, Jorn Assmann, 294584

COMPLEX KARYOTYPE IS ASSOCIATED WITH A LESS FAVORABLE OUTCOME AFTER IBRUTINIB AND RITUXIMAB AS FRONT-LINE TREATMENT OF UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (GIMEMA LLC1114)

EHA Library, Ilaria Del Giudice, 294585

ROLE OF EPIGENETICS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATHOGENESIS AND TREATMENT

EHA Library, Ana Bela Sarmento-Ribeiro, 294586

CONTRIBUTION OF ATM RARE GERMLINE VARIANTS TO GENETIC COMPLEXITY IN CLL

EHA Library, Anna Petráčková, 294587

TELOMERE LENGTH AND CD49D EXPRESSION COOPERATE WITH IGHV GENE STATUS AS PREDICTORS OF DURABLE PROGRESSION-FREE SURVIVAL IN CLL PATIENTS TREATED WITH FCR-BASED REGIMENS

EHA Library, Chris Pepper, 294588

EXPRESSION OF CD19 ANTIGEN ON CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AFTER TAFASITAMAB (ANTI-CD19) TREATMENT: PHASE I TRIAL DATA

EHA Library, Rainer Boxhammer, 294589

QUANTIFICATION OF MINIMAL RESIDUAL DISEASE BY HIGH-THROUGHPUT SEQUENCING OF IGHV GENES IN CLL

EHA Library, Marine Dupont, 294590

COMPLEX KARYOTYPE IS A STRONG PREDICTOR OF SHORT-TERM PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB.

EHA Library, Tatiana Obukhova, 294591

PROLIFERATION AND UNMUTATED IGHV STATUS ARE ASSOCIATED WITH HOMOLOGOUS RECOMBINATION ACTIVITY IN CLL CELLS

EHA Library, Shai Shimony, 294592

LANDSCAPE OF LONG NON-CODING RNA AND ROLE OF LEF1-AS1 IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lei Fan, 294593

HIGH THROUGHPUT SEQUENCING OF IGHV GENES REVEALS THE EXISTENCE OF RARE POLYCLONAL B CELLS WITH CLL TYPE STEREOTYPED BCR IN AGED HEALTHY PEOPLE

EHA Library, Marine Dupont, 294594

(SUB)CLONAL ARCHITECTURE AND TEMPORAL DYNAMICS OF THE T CELL RECEPTOR GENE REPERTOIRE IN PATIENTS WITH T-LGL PROLIFERATIONS

EHA Library, Jorn Assmann, 294596

GENE EXPRESSION IN CLL

EHA Library, Alexander Ring, 294597

PTBP1 REGULATES ALTERNATIVE SPLICING OF APOPTOTIC PROTEIN: IMPLICATIONS IN CLL AND IBRUTINIB RESISTANCE

EHA Library, Huayuan Zhu, 294598

ASSOCIATION BETWEEN EXPRESSION OF SLC28A3 GENE AND FLUDARABINE-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FLUDARABINE-CYCLOPHOSPHAMIDE CHEMOTHERAPY

EHA Library, Vojin Vukovic, 294599

INDOLEAMINE-2,3-DIOXYGENASE (IDO) AS A NEW PLAYER IN THE CROSSTALK BETWEEN LEUKEMIC CELLS AND MICROENVIRONMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Claudio Giacinto Atene, 294600

PREVALENCE, DISTRIBUTION AND PREDICTIVE VALUE OF XPO1 MUTATION IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Giulia Tueur, 294601

VARIANT ALLELE FREQUENCY OF 5% IS A SAFE AND ELIGIBLE REPORTING THRESHOLD FOR TP53 MUTATIONS DETECTED BY NEXT GENERATION SEQUENCING IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Panagiotis Baliakas, 294602

THE STUDY OF THE MOLECULAR MECHANISMS INDUCED BY NOTCH2 IN SPLENIC MARGINAL ZONE LYMPHOMA

EHA Library, Mylene Bun, 294603

BTK INHIBITOR THERAPY IS EFFECTIVE IN PATIENTS WITH CLL RESISTANT TO VENETOCLAX

EHA Library, Thomas Lew, 294604

PHASE 3B STUDY TO EVALUATE DEBULKING REGIMENS PRIOR TO INITIATING VENETOCLAX THERAPY IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jeff P. Sharman, 294605

OBINUTUZUMAB AND VENETOCLAX IN UNTREATED UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Mark-David Levin, 294606

LONG TERM RESULTS OF A PHASE I/IB STUDY OF IBRUTINIB IN COMBINATION WITH UMBRALISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL OR MCL

EHA Library, Matthew Davids, 294607

THE CHRONIC LYMPHOCYTIC LEUKEMIA-INTERNATIONAL PROGNOSTIC INDEX (CLL-IPI) CAN PREDICT OUTCOMES IN HIGH-COUNT MONOCLONAL B-CELL LYMPHOCYTOSIS AND RAI 0 CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Sameer Parikh, 294608

IMPACT OF PREMATURE VENETOCLAX (VEN) DISCONTINUATION/INTERRUPTION ON OUTCOMES IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): RESULTS FROM THE PHASE III MURANO STUDY

EHA Library, Anthony R. Mato, 294609

A PHASE IB STUDY OF SEQUENCE OF ADMINISTRATION OF IBRUTINIB PLUS OBINUTUZUMAB IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Matthew Davids, 294610

LATER TREATMENT AND EARLIER DIAGNOSIS OF DEL(17P) CLL AFTER INTRODUCTION OF TARGETED THERAPIES.

EHA Library, Christian Brieghel, 294611

EXTENDED FOLLOW-UP IN BIRC3-MUTATED RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL) PATIENTS TREATED WITH FIXED-DURATION VENETOCLAX PLUS RITUXIMAB: SUBGROUP ANALYSES OF THE MURANO TRIAL

EHA Library, Arnon P. Kater, 294612

CAUSE OF DEATH IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) STRATIFIED BY THE CLL-INTERNATIONAL PROGNOSTIC INDEX (CLL-IPI)

EHA Library, Yucai Wang, 294613

TUMOR MUTATIONAL LOAD DERIVED FROM RECURRENTLY MUTATED GENES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PREDICTS TIME-TO-FIRST TREATMENT IN HIGH-COUNT MONOCLONAL B CELL LYMPHOCYTOSIS (HC MBL)

EHA Library, Geffen Kleinstern, 294614

IGHV-ASSOCIATED METHYLATION CHANGES MORE ACCURATELY PREDICT CLINICAL OUTCOMES FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMPARED TO IGHV MUTATION STATUS

EHA Library, Tomasz K. Wojdacz, 294615

SAFETY OF ACALABRUTINIB MONOTHERAPY IN MATURE B CELL MALIGNANCIES: POOLED ANALYSIS FROM CLINICAL TRIALS

EHA Library, Paolo Ghia, 294616

CHARACTERISTICS AND OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA AND PARTIAL RESPONSE TO VENETOCLAX-OBINUTUZUMAB

EHA Library, Othman Al-Sawaf, 294617

T-GAMMA/DELTA LARGE GRANULAR LYMPHOCYTE LEUKEMIA IDENTIFIES A SUBSET OF PATIENTS WITH MORE SYMPTOMATIC DISEASE: ANALYSIS OF A COLLABORATIVE INTERNATIONAL COHORT OF 130 PATIENTS

EHA Library, Gregorio Barilà, 294618

IMPACT OF VENETOCLAX MONOTHERAPY ON THE QUALITY OF LIFE OF PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS FROM VENICE II PHASE 3B TRIAL

EHA Library, Tara Cochrane, 294619

INITIAL RESULTS OF A PHASE 1 DOSE ESCALATION STUDY EVALUATION OF MS-553, A NOVEL, SELECTIVE INHIBITOR OF PKC-BETA, IN PATIENTS WITH RELAPSED OR REFRACTORY CLL/SLL

EHA Library, James Blachly, 294620

HYPOGAMMAGLOBULINAEMIA AND INFECTIONS IN IBRUTINIB TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PAZIENTS: A PROSPECTIVE STUDY.

EHA Library, Ramona Cassin, 294621

VEMURAFENIB AS TREATMENT OPTION FOR HAIRY CELL LEUKEMIA WITH DEEP NEUTROPENIA AND INFECTIOUS COMPLICATIONS

EHA Library, Lubov Al-Radi, 294622

SAFETY AND ACTIVITY OF THE ONCE DAILY SELECTIVE BRUTON TYROSINE KINASE (BTK) INHIBITOR TG-1701 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND LYMPHOMA.

EHA Library, Chan Cheah, 294623

BTK MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKAEMIA TREATED WITH BTK INHIBITORS: A SINGLE UK INSTITUTION EXPERIENCE

EHA Library, Elisa Santambrogio, 294624

PROGNOSIS ASSESSMENT OF EARLY-STAGE CHRONIC LYMPHOCYTIC LEUKEMIA. COMPARISON OF 5 PROGNOSTIC INDEXES

EHA Library, Isabel Gonzalez-Gascon-y-Marin, 294625

EXTRAPOLATING PROGRESSION FREE SURVIVAL CURVES IN CLL USING PERIPHERAL BLOOD MRD MEASUREMENTS FROM VENETOCLAX TRIALS

EHA Library, Dimitra Alexiou, 294626

THE USE OF LONG-TERM ANTITROMBOTIC THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB.

EHA Library, Elena Emelina, 294627

RETROSPECTIVE OBSERVATIONAL STUDY OF THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH IBRUTINIB IN ROUTINE CLINICAL PRACTICE IN SPAIN

EHA Library, Pau Abrisqueta Costa, 294628

EARLY CLINICAL FINDINGS FROM A PHASE 1 A/B DOSE ESCALATION TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF CG-806 IN PATIENTS WITH RELAPSED OR REFRACTORY CLL/SLL OR NON-HODGKIN'S LYMPHOMAS

EHA Library, Rafael Bejar, 294629

PROGNOSTIC BIOMARKER TESTING AND TREATMENT SELECTION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA PRE- AND POST-APPROVAL OF NOVEL AGENTS

EHA Library, Anthony R. Mato, 294630

LOW - DOSE FCR IN THE FIRST - LINE TREATMENT OF ELDERLY / COMORBID PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA / SMALL LYMPHOCYTIC LYMPHOMA: FINAL RESULTS OF PROJECT Q-LITE BY CZECH CLL STUDY GROUP.

EHA Library, Lukáš Smolej, 294631

FRAIL PATIENTS WITH CLL CAN BE TREATED WITH NON-INTENSIVE REGIMENS WITHOUT EXCESS HOSPITALIZATIONS – A NATIONWIDE, POPULATION-BASED STUDY

EHA Library, Emelie Curovic Rotbain, 294632

THE PROGNOSTIC SIGNIFICANCE OF DELETION6Q23 DETECTED BY FLUORESCENCE IN SITU HYBRIDIZATION IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Hadiyah Ahmad, 294633

PROGNOSTIC RELEVANCE OF A 3-ITEM SCORING SYSTEM FOR INFECTION RISK IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

EHA Library, Roberta Murru, 294634

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA IN THE NEW DRUGS ERA: THE STATE OF ART IN THE ITALIAN LANDSCAPE

EHA Library, Francesca Morelli, 294635

NEUTROPENIA ANALYSIS OF VENETOCLAX MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: POOLED DATA FROM VENICE-I AND -II PHASE 3B TRIALS

EHA Library, Mary Ann Anderson, 294636

EFFECTIVENESS, SAFETY, AND ADHERENCE TO RAMP-UP MONITORING IN ELDERLY CLL PATIENTS TREATED WITH VENETOCLAX MONOTHERAPY UNDER REAL-LIFE CONDITIONS – DATA FROM THE OBSERVATIONAL STUDY VERVE

EHA Library, Ingo Schwaner, 294637

IMPACT OF TREATMENT PATTERN ON SURVIVAL IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA RECEIVING IBRUTINIB OR RITUXIMAB TREATMENT

EHA Library, Shenmiao Yang, 294638

POOR ADHERENCE TO IBRUTINIB IS NOT ASSOCIATED WITH ADVERSE OUTCOME IN RELAPSED REFRACTORY CLL PATIENTS

EHA Library, Eugene NIKITIN, 294639

THE MANAGEMENT AND USE OF HEALTHCARE RESOURCES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) INITIATING VENETOCLAX IN ROUTINE CLINICAL PRACTICE (DEVOTE) ACROSS CANADA: INTERIM ANALYSIS

EHA Library, Versha Banerji, 294640

RISK-ADAPTED BENDAMUSTINE + RITUXIMAB TREATMENT OF ELDERLY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A REGIONAL REAL-WORLD REPORT ON 159 CONSECUTIVE SWEDISH PATIENTS

EHA Library, Agnes Mattsson, 294641

MATCHING-ADJUSTED INDIRECT COMPARISONS OF EFFICACY AND SAFETY OF ACALABRUTINIB VERSUS IBRUTINIB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Matthew Davids, 294642

SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS COMPARING THERAPIES FOR TREATMENT-NAÏVE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Kavita Sail, 294643

INVESTIGATING THE IMMUNOLOGICAL INTERACTIONS AFTER TKI THERAPY CESSATION IN CML PATIENTS: PREDICTIONS AND RISK ASSESSMENT USING MATHEMATICAL MODELS

EHA Library, Elena Karg, 294645

CHARACTERIZATION OF PHENOTYPIC AND GENOTYPIC MARKERS AS PREDICTORS OF RELAPSE DURING TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Alejandro Luna, 294646

SETD2/KDM4A-MEDIATED H3K36ME3 LOSS IN CHRONIC MYELOID LEUKEMIA PATIENTS IN BLAST CRISIS CAN BE THERAPEUTICALLY TARGETED

EHA Library, Manuela Mancini, 294647

DASATINIB INDUCES ENDOTHELIAL TO MESENCHYMAL TRANSITION IN HUMAN VASCULAR ENDOTHELIAL CELLS

EHA Library, Lobna Alkebsi, 294648

THE CRISPR/CAS9 SYSTEM EFFICIENTLY REVERTS THE TUMORIGENIC ABILITY OF BCR/ABL AND RESTORING THE NORMAL HAEMATOPOIESIS IN A MOUSE MODEL OF CHRONIC MYELOGENOUS LEUKAEMIA.

EHA Library, Elena Vuelta Ramos, 294649

SNPS IN ABC GENES CORRELATES WITH MOLECULAR RESPONSE IN CML PATIENTS TREATED WITH NILOTINIB

EHA Library, Federica Loscocco, 294650

DIGITAL PCR FOR THE MEASUREMENT OF BCR- ABL1 IN CML: A NEW DAWN?

EHA Library, Stuart Scott, 294652

DIGITAL DROPLET PCR IS A FAST AND EFFECTIVE TOOL FOR DETECTING T315I MUTATION IN CHRONIC MYELOID LEUKEMIA.

EHA Library, Sara Galimberti, 294653

NOVEL MULTIPLEX DROPLET DIGITAL PCR ASSAYS TO MONITOR MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA PATIENTS SHOWING ATYPICAL BCR-ABL1 TRANSCRIPTS

EHA Library, Jessica Petiti, 294654

XPERT® BCR-ABL ULTRA: A METHOD OF MONITORING CONVERSION FACTOR STABILITY IN DIAGNOSTIC LABORATORIES

EHA Library, Kathy Dominy, 294655

IMATINIB IS ABLE TO INTERFERE WITH IMMUNE RESPONSE AND INFLAMMATION IN CHRONIC MYELOID LEUKEMIA PATIENTS: RESULTS FROM THE NANOSTRING APPLICATION.

EHA Library, Sara Galimberti, 294656

DO NOT WASTE THE DATA: A PIPELINE FOR EVALUATION OF BCR-ABL1 KINASE DOMAIN MUTATION USING INDIVIDUAL THRESHOLDS

EHA Library, Adela Benesova, 294657

DOSE OPTIMIZATION OF SECOND-LINE BOSUTINIB IN ELDERLY CML PATIENTS: FINAL RESULTS OF THE BEST STUDY

EHA Library, Fausto Castagnetti, 294658

THE RATE OF INITIAL BCR-ABL1 DECLINE AFTER COMMENCING TYROSINE KINASE INHIBITOR THERAPY IS PREDICTIVE OF BOTH TREATMENT-FREE REMISSION ELIGIBILITY AND SUBSEQUENT SUSTAINED TREATMENT-FREE REMISSION

EHA Library, Naranie Shanmuganathan, 294659

MOLECULAR RESPONSE BY 24 MONTHS OF NILOTINIB 300 MG BID TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) WHO FAILED TO ACHIEVE DMR WITH IMATINIB: RESULTS FROM THE ENESTPATH STUDY

EHA Library, Delphine Rea, 294661

CONDITIONAL RELATIVE SURVIVAL AMONG ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN THE TYROSINE KINASE INHIBITOR ERA: A POPULATION-BASED STUDY IN THE NETHERLANDS, 2001-2017

EHA Library, Geneviève Ector, 294662

INTERIM REPORT ON MOLECULAR RESPONSE AND QOL IN PATIENTS OLDER THAN 60 YEARS WITH PH+ CML IN MR3.0/MR4.0 STABLE MOLECULAR RESPONSE INTERMITTENTLY TREATED WITH TKIS (ITALIAN PHASE III OPTKIMA-STUDY)

EHA Library, Michele Malagola, 294663

HLA POLYMORPHISMS PREDICT TREATMENT-FREE REMISSION FOLLOWING TKI DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Hiroshi Ureshino, 294664

LATE MOLECULAR RECURRENCES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA EXPERIENCING TREATMENT FREE REMISSION.

EHA Library, Philippe Rousselot, 294665

IDENTIFICATION OF GENOMIC VARIANTS ASSOCIATED WITH LONG TERM MOLECULAR RESPONSE TO TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA

EHA Library, Zafar Iqbal, 294666

A PHASE 2 STUDY OF NILOTINIB (NIL) IN PEDIATRIC PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME–POSITIVE CHRONIC MYELOID LEUKEMIA (CML): ANALYSIS OF GROWTH AFTER ≥48 TREATMENT CYCLES

EHA Library, Jill Samis, 294667

BOSUTINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA INTOLERANT TO PRIOR TYROSINE KINASE INHIBITORS: ANALYSES FROM THE BYOND STUDY

EHA Library, Valentin Garcia-Gutierrez, 294668

EFFICACY AND SAFETY OF NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS WHO RELAPSED AFTER DISCONTINUATION OF IMATINIB FOR TREATMENT-FREE REMISSION: RESULTS OF THE FRENCH NILO POST-STIM STUDY

EHA Library, Stephanie Dulucq, 294669

PONATINIB AT A LOWER DOSE IS A GOOD OPTION IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS INTOLERANT TO PREVIOUS TKIS

EHA Library, Alessandra Iurlo, 294670

LONG-TERM FOLLOW UP OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS WITH CLONAL CHROMOSOMAL ABERRATIONS IN PHILADELPHIA NEGATIVE CELLS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Christos Varelas, 294671

FAVORABLE OUTCOME IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA CO-EXPRESSING E13A2 AND E14A2 TRANSCRIPT TREATED FRONTLINE WITH NILOTINIB

EHA Library, Maria Pina Simula, 294672

IS BCR-ABL1 TRANSCRIPT A RELIABLE MARKER AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT)? LONG-TERM FOLLOW-UP OF CML ALLOTRANSPLANTED PATIENTS WITH BCR/ABL1 FLUCTUATIONS

EHA Library, Antonella Antonella Bruzzese, 294673

DASATINIB IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND SUBOPTIMAL RESPONSES TO 3 MONTHS OF IMATINIB THERAPY: 3-YEAR EXTENDED FOLLOW-UP (FU) FROM DASCERN

EHA Library, Jorge Cortes, 294674

SECOND GENERATION TYROSINE KINASE INHIBITORS IN THE FIRST-LINE CAN REDUCE TIME TO TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Oleg Shukhov, 294675

TARGETING DIPEPTIDYLPEPTIDASE IV (CD26) FOR A SECOND TKI DISCONTINUATION ATTEMPT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DESIGN AND PHASE 1 RESULTS OF THE DOLPHIN-STAR STUDY.

EHA Library, Camille C.B. Kockerols, 294676